These Healthcare stocks are trading higher:
-Immuron ADR (IMRN) stock is trading at $3.71, a rise of $1.15, or 40.46%, on high volume. Immuron Limited ADR gets a Sentiment Score of Bearish from InvestorsObserver.
-Vaxxinity Inc (VAXX) stock is trading at $7.01, an increase of $1.18, or 20.24%, on high volume. Vaxxinity Inc Cl A gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $17.50.
-Erasca Inc (ERAS) stock is trading at $14.26, a gain of $1.71, or 13.55%, on moderate volume. Erasca Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $30.80. Erasca Inc next reports earnings on February 8.
-Mainz Biomed BV (MYNZ) stock is trading at $15.98, an increase of $1.89, or 13.41%, on low volume. Mainz Biomed B.V. gets a Sentiment Score of Bearish from InvestorsObserver.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Nutriband Inc (NTRB) stock is trading at $6.73, a loss of $1.42, or 17.42%, on low volume. Nutriband Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $17.00.-Koninklijke Philips NV (PHG) stock is trading at $32.84, a loss of $5.94, or 15.31%, on high volume. Koninklijke Philips Electronics gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $60.00. Koninklijke Philips Electronics next reports earnings on January 16.
-Bone Biologics Corp (BBLG) stock is trading at $3.69, a decline of $0.62, or 14.39%, on low volume. Bone Biologics Corp gets a Sentiment Score of Bearish from InvestorsObserver with a price target of $8.00.
-Aclaris Therapeutics Inc (ACRS) stock is trading at $11.05, a loss of $1.81, or 14.07%, on high volume. Aclaris Therapts gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $34.80. Aclaris Therapts next reports earnings on January 31.
